Advertisement

Index by author

November 01, 1993; Volume 44,Issue 5

A

  1. Abel, P W

    1. Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.
      F Feng, P W Abel, M Scofield, F Liu, D W Wolff and W B Jeffries
      Molecular Pharmacology November 1993, 44 (5) 926-933;

  2. Anand, R

    1. Pharmacological characterization of alpha-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of alpha 7 and alpha 8 subunit-containing subtypes.
      R Anand, X Peng, J J Ballesta and J Lindstrom
      Molecular Pharmacology November 1993, 44 (5) 1046-1050;

  3. Applegren, N

    1. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
      N R Bachur, R Johnson, F Yu, R Hickey, N Applegren and L Malkas
      Molecular Pharmacology November 1993, 44 (5) 1064-1069;

  4. Aronica, E

    1. Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors.
      E Aronica, P Dell'Albani, D F Condorelli, F Nicoletti, N Hack and R Balázs
      Molecular Pharmacology November 1993, 44 (5) 981-989;

B

  1. Bachur, N R

    1. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
      N R Bachur, R Johnson, F Yu, R Hickey, N Applegren and L Malkas
      Molecular Pharmacology November 1993, 44 (5) 1064-1069;

  2. Bajaj, R

    1. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
      S Wadler, X Mao, R Bajaj, S Hallam and E L Schwartz
      Molecular Pharmacology November 1993, 44 (5) 1070-1076;

  3. Balázs, R

    1. Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors.
      E Aronica, P Dell'Albani, D F Condorelli, F Nicoletti, N Hack and R Balázs
      Molecular Pharmacology November 1993, 44 (5) 981-989;

  4. Ballesta, J J

    1. Pharmacological characterization of alpha-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of alpha 7 and alpha 8 subunit-containing subtypes.
      R Anand, X Peng, J J Ballesta and J Lindstrom
      Molecular Pharmacology November 1993, 44 (5) 1046-1050;

  5. Banner, C D

    1. Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain.
      M Strömstedt, M Warner, C D Banner, P C MacDonald and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 1077-1083;

  6. Bell, G I

    1. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
      T Reisine, H Kong, K Raynor, H Yano, J Takeda, K Yasuda and G I Bell
      Molecular Pharmacology November 1993, 44 (5) 1016-1020;

  7. Bradfield, C A

    1. Cloning and expression of a human Ah receptor cDNA.
      K M Dolwick, J V Schmidt, L A Carver, H I Swanson and C A Bradfield
      Molecular Pharmacology November 1993, 44 (5) 911-917;

  8. Brett, R S

    1. The effects of isoflurane on acetylcholine receptor channels.: 2. Currents elicited by rapid perfusion of acetylcholine.
      J P Dilger, R S Brett and H I Mody
      Molecular Pharmacology November 1993, 44 (5) 1056-1063;

  9. Burrows, G G

    1. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies.
      F F Moebius, G G Burrows, M Hanner, E Schmid, J Striessnig and H Glossmann
      Molecular Pharmacology November 1993, 44 (5) 966-971;

C

  1. Caron, M G

    1. Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain.
      S R Nash, N Godinot and M G Caron
      Molecular Pharmacology November 1993, 44 (5) 918-925;

  2. Carver, L A

    1. Cloning and expression of a human Ah receptor cDNA.
      K M Dolwick, J V Schmidt, L A Carver, H I Swanson and C A Bradfield
      Molecular Pharmacology November 1993, 44 (5) 911-917;

  3. Chao, C C

    1. Expression of endothelin receptor subtypes in rabbit saphenous vein.
      M L Webb, E C Liu, H Monshizadegan, C C Chao, J Lynch, S M Fisher and P M Rose
      Molecular Pharmacology November 1993, 44 (5) 959-965;

  4. Chen, R

    1. Growth hormone and vitamin A induce P4502C7 mRNA expression in primary rat hepatocytes.
      S Westin, A Mode, M Murray, R Chen and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 997-1002;

  5. Chern, Y

    1. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
      Y Chern, H L Lai, J C Fong and Y Liang
      Molecular Pharmacology November 1993, 44 (5) 950-958;

  6. Chuang, D M

    1. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.
      F Fukamauchi, P A Saunders, C Hough and D M Chuang
      Molecular Pharmacology November 1993, 44 (5) 940-949;

  7. Condorelli, D F

    1. Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors.
      E Aronica, P Dell'Albani, D F Condorelli, F Nicoletti, N Hack and R Balázs
      Molecular Pharmacology November 1993, 44 (5) 981-989;

  8. Counillon, L

    1. Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties.
      L Counillon, W Scholz, H J Lang and J Pouysségur
      Molecular Pharmacology November 1993, 44 (5) 1041-1045;

  9. Cusack, B

    1. Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and agonist.
      B Cusack, E Richelson, Y P Pang, J Zaidi and A P Kozikowski
      Molecular Pharmacology November 1993, 44 (5) 1036-1040;

D

  1. De Clercq, E

    1. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
      R W Jansen, D Schols, R Pauwels, E De Clercq and D K Meijer
      Molecular Pharmacology November 1993, 44 (5) 1003-1007;

  2. Dell'Albani, P

    1. Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors.
      E Aronica, P Dell'Albani, D F Condorelli, F Nicoletti, N Hack and R Balázs
      Molecular Pharmacology November 1993, 44 (5) 981-989;

  3. Diamond, I

    1. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters.
      S W Krauss, R B Ghirnikar, I Diamond and A S Gordon
      Molecular Pharmacology November 1993, 44 (5) 1021-1026;

  4. Dilger, J P

    1. The effects of isoflurane on acetylcholine receptor channels.: 2. Currents elicited by rapid perfusion of acetylcholine.
      J P Dilger, R S Brett and H I Mody
      Molecular Pharmacology November 1993, 44 (5) 1056-1063;

  5. Dolwick, K M

    1. Cloning and expression of a human Ah receptor cDNA.
      K M Dolwick, J V Schmidt, L A Carver, H I Swanson and C A Bradfield
      Molecular Pharmacology November 1993, 44 (5) 911-917;

E

  1. Eipper, B A

    1. Peptide alpha-amidation and peptidylglycine alpha-hydroxylating monooxygenase: control by disulfiram.
      G P Mueller, E J Husten, R E Mains and B A Eipper
      Molecular Pharmacology November 1993, 44 (5) 972-980;

F

  1. Feng, F

    1. Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.
      F Feng, P W Abel, M Scofield, F Liu, D W Wolff and W B Jeffries
      Molecular Pharmacology November 1993, 44 (5) 926-933;

  2. Fisher, S M

    1. Expression of endothelin receptor subtypes in rabbit saphenous vein.
      M L Webb, E C Liu, H Monshizadegan, C C Chao, J Lynch, S M Fisher and P M Rose
      Molecular Pharmacology November 1993, 44 (5) 959-965;

  3. Fitzgerald, G A

    1. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
      C D Funk, L Furci, N Moran and G A Fitzgerald
      Molecular Pharmacology November 1993, 44 (5) 934-939;

  4. Fong, J C

    1. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
      Y Chern, H L Lai, J C Fong and Y Liang
      Molecular Pharmacology November 1993, 44 (5) 950-958;

  5. Freedman, J E

    1. Multiple sulfonylurea-sensitive potassium channels: a novel subtype modulated by dopamine.
      Y J Lin, G J Greif and J E Freedman
      Molecular Pharmacology November 1993, 44 (5) 907-910;

  6. Fukamauchi, F

    1. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.
      F Fukamauchi, P A Saunders, C Hough and D M Chuang
      Molecular Pharmacology November 1993, 44 (5) 940-949;

  7. Funk, C D

    1. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
      C D Funk, L Furci, N Moran and G A Fitzgerald
      Molecular Pharmacology November 1993, 44 (5) 934-939;

  8. Furci, L

    1. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
      C D Funk, L Furci, N Moran and G A Fitzgerald
      Molecular Pharmacology November 1993, 44 (5) 934-939;

G

  1. Ghirnikar, R B

    1. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters.
      S W Krauss, R B Ghirnikar, I Diamond and A S Gordon
      Molecular Pharmacology November 1993, 44 (5) 1021-1026;

  2. Glossmann, H

    1. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies.
      F F Moebius, G G Burrows, M Hanner, E Schmid, J Striessnig and H Glossmann
      Molecular Pharmacology November 1993, 44 (5) 966-971;

  3. Godinot, N

    1. Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain.
      S R Nash, N Godinot and M G Caron
      Molecular Pharmacology November 1993, 44 (5) 918-925;

  4. Gordon, A S

    1. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters.
      S W Krauss, R B Ghirnikar, I Diamond and A S Gordon
      Molecular Pharmacology November 1993, 44 (5) 1021-1026;

  5. Greif, G J

    1. Multiple sulfonylurea-sensitive potassium channels: a novel subtype modulated by dopamine.
      Y J Lin, G J Greif and J E Freedman
      Molecular Pharmacology November 1993, 44 (5) 907-910;

  6. Gustafsson, J A

    1. Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain.
      M Strömstedt, M Warner, C D Banner, P C MacDonald and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 1077-1083;
    2. Growth hormone and vitamin A induce P4502C7 mRNA expression in primary rat hepatocytes.
      S Westin, A Mode, M Murray, R Chen and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 997-1002;

H

  1. Hack, N

    1. Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors.
      E Aronica, P Dell'Albani, D F Condorelli, F Nicoletti, N Hack and R Balázs
      Molecular Pharmacology November 1993, 44 (5) 981-989;

  2. Hallam, S

    1. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
      S Wadler, X Mao, R Bajaj, S Hallam and E L Schwartz
      Molecular Pharmacology November 1993, 44 (5) 1070-1076;

  3. Hanner, M

    1. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies.
      F F Moebius, G G Burrows, M Hanner, E Schmid, J Striessnig and H Glossmann
      Molecular Pharmacology November 1993, 44 (5) 966-971;

  4. Hickey, R

    1. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
      N R Bachur, R Johnson, F Yu, R Hickey, N Applegren and L Malkas
      Molecular Pharmacology November 1993, 44 (5) 1064-1069;

  5. Hough, C

    1. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.
      F Fukamauchi, P A Saunders, C Hough and D M Chuang
      Molecular Pharmacology November 1993, 44 (5) 940-949;

  6. Howlett, A C

    1. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
      L S Melvin, G M Milne, M R Johnson, B Subramaniam, G H Wilken and A C Howlett
      Molecular Pharmacology November 1993, 44 (5) 1008-1015;

  7. Husten, E J

    1. Peptide alpha-amidation and peptidylglycine alpha-hydroxylating monooxygenase: control by disulfiram.
      G P Mueller, E J Husten, R E Mains and B A Eipper
      Molecular Pharmacology November 1993, 44 (5) 972-980;

J

  1. Jansen, R W

    1. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
      R W Jansen, D Schols, R Pauwels, E De Clercq and D K Meijer
      Molecular Pharmacology November 1993, 44 (5) 1003-1007;

  2. Jeffries, W B

    1. Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.
      F Feng, P W Abel, M Scofield, F Liu, D W Wolff and W B Jeffries
      Molecular Pharmacology November 1993, 44 (5) 926-933;

  3. Johnson, M R

    1. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
      L S Melvin, G M Milne, M R Johnson, B Subramaniam, G H Wilken and A C Howlett
      Molecular Pharmacology November 1993, 44 (5) 1008-1015;

  4. Johnson, R

    1. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
      N R Bachur, R Johnson, F Yu, R Hickey, N Applegren and L Malkas
      Molecular Pharmacology November 1993, 44 (5) 1064-1069;

K

  1. Kong, H

    1. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
      T Reisine, H Kong, K Raynor, H Yano, J Takeda, K Yasuda and G I Bell
      Molecular Pharmacology November 1993, 44 (5) 1016-1020;

  2. Kozikowski, A P

    1. Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and agonist.
      B Cusack, E Richelson, Y P Pang, J Zaidi and A P Kozikowski
      Molecular Pharmacology November 1993, 44 (5) 1036-1040;

  3. Krauss, S W

    1. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters.
      S W Krauss, R B Ghirnikar, I Diamond and A S Gordon
      Molecular Pharmacology November 1993, 44 (5) 1021-1026;

L

  1. Lagarde, M

    1. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
      P Marcoz, A F Prigent, M Lagarde and G Nemoz
      Molecular Pharmacology November 1993, 44 (5) 1027-1035;

  2. Lai, H L

    1. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
      Y Chern, H L Lai, J C Fong and Y Liang
      Molecular Pharmacology November 1993, 44 (5) 950-958;

  3. Lang, H J

    1. Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties.
      L Counillon, W Scholz, H J Lang and J Pouysségur
      Molecular Pharmacology November 1993, 44 (5) 1041-1045;

  4. Liang, Y

    1. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
      Y Chern, H L Lai, J C Fong and Y Liang
      Molecular Pharmacology November 1993, 44 (5) 950-958;

  5. Lin, Y J

    1. Multiple sulfonylurea-sensitive potassium channels: a novel subtype modulated by dopamine.
      Y J Lin, G J Greif and J E Freedman
      Molecular Pharmacology November 1993, 44 (5) 907-910;

  6. Lindstrom, J

    1. Pharmacological characterization of alpha-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of alpha 7 and alpha 8 subunit-containing subtypes.
      R Anand, X Peng, J J Ballesta and J Lindstrom
      Molecular Pharmacology November 1993, 44 (5) 1046-1050;

  7. Liu, E C

    1. Expression of endothelin receptor subtypes in rabbit saphenous vein.
      M L Webb, E C Liu, H Monshizadegan, C C Chao, J Lynch, S M Fisher and P M Rose
      Molecular Pharmacology November 1993, 44 (5) 959-965;

  8. Liu, F

    1. Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.
      F Feng, P W Abel, M Scofield, F Liu, D W Wolff and W B Jeffries
      Molecular Pharmacology November 1993, 44 (5) 926-933;

  9. Lynch, J

    1. Expression of endothelin receptor subtypes in rabbit saphenous vein.
      M L Webb, E C Liu, H Monshizadegan, C C Chao, J Lynch, S M Fisher and P M Rose
      Molecular Pharmacology November 1993, 44 (5) 959-965;

M

  1. MacDonald, P C

    1. Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain.
      M Strömstedt, M Warner, C D Banner, P C MacDonald and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 1077-1083;

  2. Mains, R E

    1. Peptide alpha-amidation and peptidylglycine alpha-hydroxylating monooxygenase: control by disulfiram.
      G P Mueller, E J Husten, R E Mains and B A Eipper
      Molecular Pharmacology November 1993, 44 (5) 972-980;

  3. Malkas, L

    1. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
      N R Bachur, R Johnson, F Yu, R Hickey, N Applegren and L Malkas
      Molecular Pharmacology November 1993, 44 (5) 1064-1069;

  4. Mao, X

    1. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
      S Wadler, X Mao, R Bajaj, S Hallam and E L Schwartz
      Molecular Pharmacology November 1993, 44 (5) 1070-1076;

  5. Marcoz, P

    1. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
      P Marcoz, A F Prigent, M Lagarde and G Nemoz
      Molecular Pharmacology November 1993, 44 (5) 1027-1035;

  6. Meijer, D K

    1. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
      R W Jansen, D Schols, R Pauwels, E De Clercq and D K Meijer
      Molecular Pharmacology November 1993, 44 (5) 1003-1007;

  7. Melvin, L S

    1. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
      L S Melvin, G M Milne, M R Johnson, B Subramaniam, G H Wilken and A C Howlett
      Molecular Pharmacology November 1993, 44 (5) 1008-1015;

  8. Milne, G M

    1. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
      L S Melvin, G M Milne, M R Johnson, B Subramaniam, G H Wilken and A C Howlett
      Molecular Pharmacology November 1993, 44 (5) 1008-1015;

  9. Mode, A

    1. Growth hormone and vitamin A induce P4502C7 mRNA expression in primary rat hepatocytes.
      S Westin, A Mode, M Murray, R Chen and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 997-1002;

  10. Mody, H I

    1. The effects of isoflurane on acetylcholine receptor channels.: 2. Currents elicited by rapid perfusion of acetylcholine.
      J P Dilger, R S Brett and H I Mody
      Molecular Pharmacology November 1993, 44 (5) 1056-1063;

  11. Moebius, F F

    1. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies.
      F F Moebius, G G Burrows, M Hanner, E Schmid, J Striessnig and H Glossmann
      Molecular Pharmacology November 1993, 44 (5) 966-971;

  12. Monshizadegan, H

    1. Expression of endothelin receptor subtypes in rabbit saphenous vein.
      M L Webb, E C Liu, H Monshizadegan, C C Chao, J Lynch, S M Fisher and P M Rose
      Molecular Pharmacology November 1993, 44 (5) 959-965;

  13. Moran, N

    1. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
      C D Funk, L Furci, N Moran and G A Fitzgerald
      Molecular Pharmacology November 1993, 44 (5) 934-939;

  14. Mueller, G P

    1. Peptide alpha-amidation and peptidylglycine alpha-hydroxylating monooxygenase: control by disulfiram.
      G P Mueller, E J Husten, R E Mains and B A Eipper
      Molecular Pharmacology November 1993, 44 (5) 972-980;

  15. Murray, M

    1. Growth hormone and vitamin A induce P4502C7 mRNA expression in primary rat hepatocytes.
      S Westin, A Mode, M Murray, R Chen and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 997-1002;

N

  1. Nash, S R

    1. Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain.
      S R Nash, N Godinot and M G Caron
      Molecular Pharmacology November 1993, 44 (5) 918-925;

  2. Nemoz, G

    1. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
      P Marcoz, A F Prigent, M Lagarde and G Nemoz
      Molecular Pharmacology November 1993, 44 (5) 1027-1035;

  3. Nicoletti, F

    1. Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors.
      E Aronica, P Dell'Albani, D F Condorelli, F Nicoletti, N Hack and R Balázs
      Molecular Pharmacology November 1993, 44 (5) 981-989;

O

  1. Omiecinski, C J

    1. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain.
      B Schilter and C J Omiecinski
      Molecular Pharmacology November 1993, 44 (5) 990-996;

P

  1. Pang, Y P

    1. Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and agonist.
      B Cusack, E Richelson, Y P Pang, J Zaidi and A P Kozikowski
      Molecular Pharmacology November 1993, 44 (5) 1036-1040;

  2. Pauwels, R

    1. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
      R W Jansen, D Schols, R Pauwels, E De Clercq and D K Meijer
      Molecular Pharmacology November 1993, 44 (5) 1003-1007;

  3. Peng, X

    1. Pharmacological characterization of alpha-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of alpha 7 and alpha 8 subunit-containing subtypes.
      R Anand, X Peng, J J Ballesta and J Lindstrom
      Molecular Pharmacology November 1993, 44 (5) 1046-1050;

  4. Pouysségur, J

    1. Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties.
      L Counillon, W Scholz, H J Lang and J Pouysségur
      Molecular Pharmacology November 1993, 44 (5) 1041-1045;

  5. Prigent, A F

    1. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
      P Marcoz, A F Prigent, M Lagarde and G Nemoz
      Molecular Pharmacology November 1993, 44 (5) 1027-1035;

R

  1. Raynor, K

    1. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
      T Reisine, H Kong, K Raynor, H Yano, J Takeda, K Yasuda and G I Bell
      Molecular Pharmacology November 1993, 44 (5) 1016-1020;

  2. Reisine, T

    1. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
      T Reisine, H Kong, K Raynor, H Yano, J Takeda, K Yasuda and G I Bell
      Molecular Pharmacology November 1993, 44 (5) 1016-1020;

  3. Richelson, E

    1. Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and agonist.
      B Cusack, E Richelson, Y P Pang, J Zaidi and A P Kozikowski
      Molecular Pharmacology November 1993, 44 (5) 1036-1040;

  4. Rose, P M

    1. Expression of endothelin receptor subtypes in rabbit saphenous vein.
      M L Webb, E C Liu, H Monshizadegan, C C Chao, J Lynch, S M Fisher and P M Rose
      Molecular Pharmacology November 1993, 44 (5) 959-965;

S

  1. Saunders, P A

    1. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.
      F Fukamauchi, P A Saunders, C Hough and D M Chuang
      Molecular Pharmacology November 1993, 44 (5) 940-949;

  2. Schilter, B

    1. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain.
      B Schilter and C J Omiecinski
      Molecular Pharmacology November 1993, 44 (5) 990-996;

  3. Schmid, E

    1. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies.
      F F Moebius, G G Burrows, M Hanner, E Schmid, J Striessnig and H Glossmann
      Molecular Pharmacology November 1993, 44 (5) 966-971;

  4. Schmidt, J V

    1. Cloning and expression of a human Ah receptor cDNA.
      K M Dolwick, J V Schmidt, L A Carver, H I Swanson and C A Bradfield
      Molecular Pharmacology November 1993, 44 (5) 911-917;

  5. Schols, D

    1. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
      R W Jansen, D Schols, R Pauwels, E De Clercq and D K Meijer
      Molecular Pharmacology November 1993, 44 (5) 1003-1007;

  6. Scholz, W

    1. Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties.
      L Counillon, W Scholz, H J Lang and J Pouysségur
      Molecular Pharmacology November 1993, 44 (5) 1041-1045;

  7. Schwartz, E L

    1. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
      S Wadler, X Mao, R Bajaj, S Hallam and E L Schwartz
      Molecular Pharmacology November 1993, 44 (5) 1070-1076;

  8. Scofield, M

    1. Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.
      F Feng, P W Abel, M Scofield, F Liu, D W Wolff and W B Jeffries
      Molecular Pharmacology November 1993, 44 (5) 926-933;

  9. Striessnig, J

    1. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies.
      F F Moebius, G G Burrows, M Hanner, E Schmid, J Striessnig and H Glossmann
      Molecular Pharmacology November 1993, 44 (5) 966-971;

  10. Strömstedt, M

    1. Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain.
      M Strömstedt, M Warner, C D Banner, P C MacDonald and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 1077-1083;

  11. Subramaniam, B

    1. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
      L S Melvin, G M Milne, M R Johnson, B Subramaniam, G H Wilken and A C Howlett
      Molecular Pharmacology November 1993, 44 (5) 1008-1015;

  12. Swanson, H I

    1. Cloning and expression of a human Ah receptor cDNA.
      K M Dolwick, J V Schmidt, L A Carver, H I Swanson and C A Bradfield
      Molecular Pharmacology November 1993, 44 (5) 911-917;

T

  1. Takeda, J

    1. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
      T Reisine, H Kong, K Raynor, H Yano, J Takeda, K Yasuda and G I Bell
      Molecular Pharmacology November 1993, 44 (5) 1016-1020;

W

  1. Wachtel, R E

    1. Physostigmine block of ion channels activated by acetylcholine in BC3H1 cells.
      R E Wachtel
      Molecular Pharmacology November 1993, 44 (5) 1051-1055;

  2. Wadler, S

    1. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
      S Wadler, X Mao, R Bajaj, S Hallam and E L Schwartz
      Molecular Pharmacology November 1993, 44 (5) 1070-1076;

  3. Warner, M

    1. Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain.
      M Strömstedt, M Warner, C D Banner, P C MacDonald and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 1077-1083;

  4. Webb, M L

    1. Expression of endothelin receptor subtypes in rabbit saphenous vein.
      M L Webb, E C Liu, H Monshizadegan, C C Chao, J Lynch, S M Fisher and P M Rose
      Molecular Pharmacology November 1993, 44 (5) 959-965;

  5. Westin, S

    1. Growth hormone and vitamin A induce P4502C7 mRNA expression in primary rat hepatocytes.
      S Westin, A Mode, M Murray, R Chen and J A Gustafsson
      Molecular Pharmacology November 1993, 44 (5) 997-1002;

  6. Wilken, G H

    1. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
      L S Melvin, G M Milne, M R Johnson, B Subramaniam, G H Wilken and A C Howlett
      Molecular Pharmacology November 1993, 44 (5) 1008-1015;

  7. Wolff, D W

    1. Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.
      F Feng, P W Abel, M Scofield, F Liu, D W Wolff and W B Jeffries
      Molecular Pharmacology November 1993, 44 (5) 926-933;

Y

  1. Yano, H

    1. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
      T Reisine, H Kong, K Raynor, H Yano, J Takeda, K Yasuda and G I Bell
      Molecular Pharmacology November 1993, 44 (5) 1016-1020;

  2. Yasuda, K

    1. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
      T Reisine, H Kong, K Raynor, H Yano, J Takeda, K Yasuda and G I Bell
      Molecular Pharmacology November 1993, 44 (5) 1016-1020;

  3. Yu, F

    1. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
      N R Bachur, R Johnson, F Yu, R Hickey, N Applegren and L Malkas
      Molecular Pharmacology November 1993, 44 (5) 1064-1069;

Z

  1. Zaidi, J

    1. Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and agonist.
      B Cusack, E Richelson, Y P Pang, J Zaidi and A P Kozikowski
      Molecular Pharmacology November 1993, 44 (5) 1036-1040;
Back to top

In this issue